Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapy crawled date : 2021 - 11 - 09 save search
Aravive Announces Positive Preliminary Data from Phase 1b Trial Evaluating Batiraxcept (AVB-500) in Combination with Cabozantinib in Clear Cell Renal Cell Carcinoma to be Presented at 2021 Society for Immunotherapy of Cancer Annual Meeting
Published: 2021-11-09 (Crawled : 19:00) - biospace.com/
ARAV | $0.0401 4.74% 4M
|
Health Technology
|
| O: 1.47%
H: 2.91%
C: -2.42%
immunotherapy phase 1 renal positive therapy cancer phase 1b trial phase 2b cell carcinoma
Immunocore presents new data on tebentafusp in metastatic cutaneous melanoma (mCM) and uveal melanoma (mUM) at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
Published: 2021-11-09 (Crawled : 19:00) - biospace.com/
IMCR | $58.47 2.02% 2.07% 0
|
Manufacturing
| Email alert
Add to watchlist
immunotherapy therapy cancer
Jasper Therapeutics Announces Research Collaboration with AVROBIO to Evaluate JSP191 as Conditioning Agent in Clinical Studies of Ex Vivo Lentiviral Gene Therapy
Published: 2021-11-09 (Crawled : 19:00) - biospace.com/
JSPR | $22.03 -0.36% -0.14% 5
|
|
| O: -2.22%
H: 0.0%
C: 0.0%
AVRO | $1.19 -1.65% -1.26% 0
|
Health Technology
|
| O: -1.63%
H: 0.5%
C: -3.64%
gene therapy therapy collaboration research
aTyr Pharma Presents Research Demonstrating Effects of Novel NRP2-Targeting Antibody, ATYR2810, on Tumor Associated Macrophages at the Society for Immunotherapy of Cancer Annual Meeting
Published: 2021-11-09 (Crawled : 17:00) - biospace.com/
LIFE | $1.6 -1.23% -1.57% 0
|
Health Technology
|
| O: -0.47%
H: 2.73%
C: 2.02%
immunotherapy therapy cancer antibody research
Nektar Therapeutics to Host Webcast Conference Call for Analysts & Investors with Cancer Specialist During 2021 Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
Published: 2021-11-09 (Crawled : 15:15) - biospace.com/
NKTR | News | $1.38 -2.82% -2.16% 1.8K
|
Health Technology
|
| O: -0.96%
H: 1.24%
C: -4.76%
immunotherapy therapy cancer conference
Precision BioSciences to Highlight Capabilities of ARCUS Gene Editing for Allogeneic CAR T Cell Immunotherapies at The Society for Immunotherapy of Cancer 36th Annual Meeting
Published: 2021-11-09 (Crawled : 14:15) - biospace.com/
DTIL | $9.82 3.3K
|
Health Technology
|
| O: -2.04%
H: 0.0%
C: 0.0%
immunotherapy therapy cancer arcus car-t t-cell
Iovance Biotherapeutics Announces Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Cell Therapy in Multiple Solid Tumors at Society for Immunotherapy of Cancer (SITC) Annual Meeting
Published: 2021-11-09 (Crawled : 14:00) - globenewswire.com
IOVA 4 | $11.71 -1.27% -1.45% 1.6K
|
Health Technology
|
| O: -0.36%
H: 4.65%
C: -0.64%
immunotherapy solid tumors therapy cancer iot
Poseida Therapeutics to Present Preclinical Data Highlighting Fully Allogeneic CAR-T Product Candidates at the Society for Immunotherapy of Cancer 2021 Annual Meeting
Published: 2021-11-09 (Crawled : 13:15) - prnewswire.com
PSTX | $2.07 -4.17% -4.6% 0
|
Health Technology
|
| O: -1.96%
H: 0.0%
C: 0.0%
immunotherapy therapy car-t cancer preclinical pre-clinical
Intra-Cellular Therapies Reports Third Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-11-09 (Crawled : 13:00) - globenewswire.com
ITCI 4 d | $73.12 -1.2% -3.19% 7
|
Health Technology
|
| O: -2.02%
H: 3.23%
C: 0.14%
financial results results therapy
COMPASS Pathways announces positive topline results from groundbreaking phase IIb trial of investigational COMP360 psilocybin therapy for treatment-resistant depression
Published: 2021-11-09 (Crawled : 12:15) - globenewswire.com
CMPS | $7.95 -1.85% 110K
|
Health Technology
|
| O: -17.57%
H: 3.31%
C: -11.45%
treatment positive therapy results topline depression trial comp360 psilocybin
Global Depth Filtration Market 2021-2026 - Depth Filtration Quickens Ascent to the Top of the Game in Gene Therapies
Published: 2021-11-09 (Crawled : 11:00) - prnewswire.com
PH | News | $546.35 -0.74% 0.0% 8
|
Producer Manufacturing
|
| O: 0.22%
H: 0.82%
C: -0.22%
MMM | $92.02 -1.05% -0.21% 3K
|
Producer Manufacturing
|
| O: -0.71%
H: 0.0%
C: 0.0%
gene therapies gene therapy therapy
Gainers vs Losers
| 50% | 50% |
Top 10 Gainers
CSSE 4 | $0.299 96.32% 7M
|
Consumer Services
BRFH 4 | $1.99 80.91% 13M
|
Manufacturing
BOF | $1.915 63.68% 620K
|
AMST | $3.13 56.5% 500K
|
Technology Services
ACON | $0.3595 24.83% 3.5M
|
n/a
CDTX | News | $14.57 18.55% 330K
|
Health Technology
ULBI M | $10.12 15.92% 120K
|
Producer Manufacturing
LRHC | $1.79 11.88% 3K
|
n/a
AIXI | $1.34 8.94% 42K
|
n/a
TRU | $74.475 8.44% 100K
|
Technology Services
Your saved searches
Save your searches and get alerts when important news are released.